Exercise of Options and Issue of Shares

NetScientific PLC
05 February 2024
 

http://netscientific.net/addons/default/themes/bootstrap/img/logo.pngFor release on RNS: 07.00, 5 February 2024

 

 

 

 

NetScientific plc

("NetScientific" or the "Company")

 

Exercise of Options and Issue of Shares

NetScientific Plc (AIM: NSCI), the deep tech and life sciences VC investment group, announces the exercise by John Clarkson (former NetScientific Chair) of options over 254,977 ordinary shares in the capital of NetScientific Plc ("Ordinary Shares") for an aggregate exercise price of £116,014.54 and the subscription for 116,548 new Ordinary Shares by John Clarkson and two other service providers to the Company.

In addition to this options exercise, the following new Ordinary Shares have been issued:

·    John Clarkson has subscribed for 4,728 new Ordinary Shares at a price of £0.626 per share, such price being determined by reference to the average of the closing market quotations for Ordinary Shares over the five dealing days prior to 2 February 2024 (Issue Price). Such shares have been issued in settlement of monies due to John Clarkson as settlement of fees due to him in connection with services provided by him to the NetScientific group;

·    EcoMachines Ventures Limited has subscribed for 95,846 new Ordinary Shares at the Issue Price. Such shares have been issued in settlement of monies due to that company in connection with an agreement relating to the EMV Capital Evergreen EIS Fund; and

·    MJG 1968 Consulting Limited has subscribed for 15,974 new Ordinary Shares at the Issue Price. Such shares have been issued in settlement of monies due to that company in connection with advisory services provided by it to the NetScientific group.

Application will be made for 371,525 new Ordinary Shares, which will rank pari passu with existing Ordinary Shares, to be admitted to AIM ("Admission"). It is expected that Admission will become effective and dealings will commence at 8.00 a.m. on or around 8 February 2024.

Following Admission, the total issued share capital of the Company will consist of 23,945,828 Ordinary Shares ("Enlarged Issued Share Capital"). The Company does not hold any shares in treasury. Therefore, the total number of voting rights in the Company will be 23,945,828 Ordinary Shares. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The person responsible for arranging the release of this announcement on behalf of the Company is Edward Hooper, General Counsel and Executive Director of the Company.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

-Ends-

 

NetScientific

NetScientific


Ilian Iliev, CEO

Via Belvedere Communications

 

 

Panmure Gordon (UK) Limited (NOMAD and Broker)

 

Emma Earl / Freddy Crossley / Will Goode / Mark Rogers (Corporate Finance)

Rupert Dearden (Corporate Broking)

+44 (0)20 7886 2500



Belvedere Communications

John West / Llew Angus / Lily Pearce

 

+44 (0)20 7653 8702

 

About NetScientific

NetScientific plc (AIM: NSCI) is a deep tech and life sciences VC investment group with an international portfolio of innovative companies.

NetScientific identifies, invests in, and builds high growth companies in the UK and internationally. The company adds value through the proactive management of its portfolio, progressing to key value inflection points, and delivering investment returns through partial or full liquidity events.

NetScientific differentiates itself by employing a capital-efficient investment approach, making judicial use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital. The group secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a lean structure that can support a large portfolio.

NetScientific is headquartered in London, United Kingdom, and is admitted to trading on AIM, a market operated by the London Stock Exchange.

www.netscientific.net

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Emv Capital (EMVC)
UK 100

Latest directors dealings